False-positive ¹¹¹ In-pentetreotide Uptake in Gastritis

¹¹¹ In-pentetreotide [ ¹¹¹ In-octreoscan] is the most widely used radiolabeled somatostatin analog for evaluating neuroendocrine tumor overexpression of somatostatin receptors. False-positives studies of somatostatin receptor scintigraphy have been reported and often the cause is unexplained but assumed to be due to high number of somatostatin receptors in other pathologies. Causes of false-positives include visualization of the gallbladder, nasal mucosa and pulmonary hilar areas in respiratory infections, thyroid abnormalities, accessory spleens, recent Cerebrovascular accidents (CVA′s) and activity at the site of a recent surgical incision. In infection or inflammation the cause of false-positive uptake is probably the result of tracer binding by somatostatin receptors on the inflammatory leukocytes. In this case report, we report, a 44-year-old male patient with false-positive ¹¹¹ In-pentetreotide uptake due to gastritis.

Keywords

¹¹¹ In-pentetreotide - false positive - gastritis

Publication History

Article published online:
21 May 2022